BDR Pharma launches anti-cancer drug Furmecil EP News Bureau Apr 20, 2022 Furmecil is an oral drug, indicated in adults for the treatment of advanced gastric cancer
Researchers from IIT Madras identify alternative source for anti-cancer drug Camptothecin EP News Bureau Feb 25, 2021 At present, this drug is sourced from Chinese and Indian tree species, which are now critically endangered due to extensive…
Trodelvy from Immunomedics extends survival in breast cancer patients Reuters Sep 19, 2020 The FDA granted the drug accelerated approval for its use in metastatic triple-negative breast cancer (mTNBC) patients who had…
Shilpa Medicare IBRUSHIL for treatment of leukaemia EP News Bureau May 28, 2020 Earlier it had launched Lenvatinib ‘LENSHIL and Dasatinib ‘DASASHIL’ in the India market
Shilpa Medicare launches cancer drug at monthly therapy cost of Rs 6,440 Press Trust of India Apr 27, 2020 Shilpa Medicare has launched the Indian branded generic of Dasatinib, an anti-cancer drug with a brand name Dasashil